PT-141 - Hilma Biocare

PT-141 is the laboratory name for Bremelanotide, a peptide derived from Melanotan II without the amide C terminus. Its primary role is the treatment of sexual disorders involving reduced libido, impaired arousal and erectile dysfunction.

Unlike products that rely mainly on blood vessel dilation, PT-141 begins its action in the central nervous system. It activates the MC3R and MC4R melanocortin receptors that control desire and sexual response, addressing arousal at its neurological source rather than focusing only on genital blood flow.

This central mechanism makes Bremelanotide suitable for men and women. It can increase desire, improve erectile response and strengthen sensitivity without long term hormonal suppression or dependency.